ArticleClinical cancer research : an official journal of the American Association for Cancer Research2021

Phase Ib Dose Expansion and Translational Analyses of Olaparib in Combination with Capivasertib in Recurrent Endometrial, Triple-Negative Breast, and Ovarian Cancer.

Shannon N Westin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.